Digest Network Come funziona
Network
/
Società
Sp
Non verificato

Spruce Biosciences, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

27 comunicati stampa

Guarda tutti i comunicati
09/03/2026
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
09/03/2026
Mercato del lavoro
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
02/03/2026
Web e Social Network
Eventi
Salute
Scienza
Farmaceutica
Biotecnologia
Spruce Biosciences to Present at Upcoming Investor Conferences in March
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
18/02/2026
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
17/02/2026
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
05/02/2026
Eventi
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Long-Term Data Presented at the 22nd Annual WORLDSymposium™ Highlights Tralesinidase Alfa Enzyme Replacement Therapy’s Potential as the First Disease-Modifying Treatment Option for Sanfilippo Syndrome Type B (MPS IIIB)
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
03/02/2026
Mercato del lavoro
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
28/01/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Eventi
Industria
Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
08/01/2026
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
15/12/2025
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0